Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.820
-0.340 (-8.17%)
At close: Nov 20, 2024, 4:00 PM
2.260
-1.560 (-40.84%)
After-hours: Nov 20, 2024, 7:59 PM EST
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $227.16 million as of November 20, 2024. Its market cap has increased by 197.82% in one year.
Market Cap
227.16M
Enterprise Value
102.88M
1-Year Change
197.82%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $227.16M, a decrease of -56.63%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 247.38M | 210.20% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 256.77M |
| Ocugen | 254.50M |
| Anika Therapeutics | 249.56M |
| Zynex | 249.03M |
| Fate Therapeutics | 248.29M |
| LifeMD | 240.82M |
| Inventiva | 239.73M |
| Pulmonx | 236.93M |